Properdin contributes to allergic airway inflammation through local C3a generation

Journal of Immunology

Volumn 195, Issue 3, 2015, Pages 1171-1181

  Wang, Yuan ^a   Miwa, Takashi ^a   Ducka Kokalari, Blerina ^a   Redai, Imre G ^a   Sato, Sayaka ^a   Gullipalli, Damodar ^a   Zangrilli, James G ^b   Haczku, Angela ^a   Song, Wen Chao ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; IMMUNOGLOBULIN E; PROPERDIN; METHACHOLINE CHLORIDE;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; PROTEIN TARGETING; SENSITIZATION; TH2 CELL; ANIMAL; ASTHMA; BIOSYNTHESIS; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; EOSINOPHIL; GENETICS; IMMUNOLOGY; INFLAMMATION; LEUKOCYTE COUNT; LUNG; PATHOLOGY; TH17 CELL;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; COMPLEMENT C3A; EOSINOPHILS; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LUNG; METHACHOLINE CHLORIDE; MICE; MICE, INBRED C57BL; PROPERDIN; TH17 CELLS; TH2 CELLS;

EID: 84937705037     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401819     Document Type: Article

References (67)

1. Fahy, J. V., D. B. Corry, and H. A. Boushey. 2000. Airway inflammation and remodeling in asthma. Curr. Opin. Pulm. Med. 6: 15-20.
2. Rogers, L., and J. Reibman. 2011. Pharmacologic approaches to life-threatening asthma. Ther. Adv. Respir. Dis. 5: 397-408.
3. Herrick, C. A., and K. Bottomly. 2003. To respond or not to respond: T cells in allergic asthma. Nat. Rev. Immunol. 3: 405-412.
4. Larché, M., D. S. Robinson, and A. B. Kay. 2003. The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111: 450-463, quiz 464.
5. Hamelmann, E., U.Wahn, and E.W. Gelfand. 1999. Role of the Th2 cytokines in the development of allergen-induced airway inflammation and hyperresponsiveness. Int. Arch. Allergy Immunol. 118: 90-94.
6. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17: 255-281.
7. Suarez, C. J., N. J. Parker, and P. W. Finn. 2008. Innate immune mechanism in allergic asthma. Curr. Allergy Asthma Rep. 8: 451-459.
8. Dombrowicz, D. 2005. Exploiting the innate immune system to control allergic asthma. Eur. J. Immunol. 35: 2786-2788.
9. Vercelli, D., J. Gozdz, and E. von Mutius. 2014. Innate lymphoid cells in asthma: when innate immunity comes in a Th2 flavor. Curr. Opin. Allergy Clin. Immunol. 14: 29-34.
10. Deckers, J., F. Branco Madeira, and H. Hammad. 2013. Innate immune cells in asthma. Trends Immunol. 34: 540-547.
11. Humbles, A. A., B. Lu, C. A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N. P. Gerard, and C. Gerard. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406: 998-1001.
12. Abe, M., K. Shibata, H. Akatsu, N. Shimizu, N. Sakata, T. Katsuragi, and H. Okada. 2001. Contribution of anaphylatoxin C5a to late airway responses after repeated exposure of antigen to allergic rats. J. Immunol. 167: 4651-4660.
13. Drouin, S. M., D. B. Corry, T. J. Hollman, J. Kildsgaard, and R. A. Wetsel. 2002. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 169: 5926-5933.
14. Baelder, R., B. Fuchs, W. Bautsch, J. Zwirner, J. Köhl, H. G. Hoymann, T. Glaab, V. Erpenbeck, N. Krug, and A. Braun. 2005. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation. J. Immunol. 174: 783-789.
15. Köhl, J., R. Baelder, I. P. Lewkowich, M. K. Pandey, H. Hawlisch, L. Wang, J. Best, N. S. Herman, A. A. Sproles, J. Zwirner, et al. 2006. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116: 783-796.
16. Walters, D. M., P. N. Breysse, B. Schofield, and M. Wills-Karp. 2002. Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 27: 413-418.
17. Zhang, X., and J. Köhl. 2010. A complex role for complement in allergic asthma. Expert Rev. Clin. Immunol. 6: 269-277.
18. Lukacs, N. W., M. M. Glovsky, and P. A. Ward. 2001. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L512-L518.
19. Wills-Karp, M. 2007. Complement activation pathways: a bridge between innate and adaptive immune responses in asthma. Proc. Am. Thorac. Soc. 4: 247-251.
20. Hawlisch, H., M. Wills-Karp, C. L. Karp, and J. Kö hl. 2004. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol. Immunol. 41: 123-131.
21. Schwaeble, W. J., and K. B. Reid. 1999. Does properdin crosslink the cellular and the humoral immune response? Immunol. Today 20: 17-21.
22. Fearon, D. T., and K. F. Austen. 1975. Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J. Exp. Med. 142: 856-863.
23. Hourcade, D. E. 2006. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. J. Biol. Chem. 281: 2128-2132.
24. Bathum, L., H. Hansen, B. Teisner, C. Koch, P. Garred, K. Rasmussen, and P. Wang. 2006. Association between combined properdin and mannose-binding lectin deficiency and infection with Neisseria meningitidis. Mol. Immunol. 43: 473-479.
25. Späth, P. J., A. G. Sjöholm, G. N. Fredrikson, G. Misiano, R. Scherz, U. B. Schaad, B. Uhring-Lambert, G. Hauptmann, J. Westberg, M. Uhlén, et al. 1999. Properdin deficiency in a large Swiss family: identification of a stop codon in the properdin gene, and association of meningococcal disease with lack of the IgG2 allotype marker G2m(n). Clin. Exp. Immunol. 118: 278-284.
26. Gelfand, E. W., C. P. Rao, J. O. Minta, T. Ham, D. B. Purkall, and S. Ruddy. 1987. Inherited deficiency of properdin and C2 in a patient with recurrent bacteremia. Am. J. Med. 82: 671-675.
27. Linton, S. M., and B. P. Morgan. 1999. Properdin deficiency and meningococcal disease-identifying those most at risk. Clin. Exp. Immunol. 118: 189-191.
28. Miwa, T., S. Sato, D. Gullipalli, M. Nangaku, and W. C. Song. 2013. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-Accelerating factor and CD59 doubleknockout mice. J. Immunol. 190: 3552-3559.
29. Kimura, Y., L. Zhou, T. Miwa, and W. C. Song. 2010. Genetic and therapeutic targeting of properdin in mice prevents complement-mediated tissue injury. J. Clin. Invest. 120: 3545-3554.
30. Lesher, A. M., L. Zhou, Y. Kimura, S. Sato, D. Gullipalli, A. P. Herbert, P. N. Barlow, H. U. Eberhardt, C. Skerka, P. F. Zipfel, et al. 2013. Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. J. Am. Soc. Nephrol. 24: 53-65.
31. Batra, V., A. I. Musani, A. T. Hastie, S. Khurana, K. A. Carpenter, J. G. Zangrilli, and S. P. Peters. 2004. Bronchoalveolar lavage fluid concentrations of transforming growth factor (TGF)-beta1, TGF-beta2, interleukin (IL)-4 and IL-13 after segmental allergen challenge and their effects on alpha-smooth muscle actin and collagen III synthesis by primary human lung fibroblasts. Clin. Exp. Allergy 34: 437-444.
32. Sly, R. M. 1997. New guidelines for diagnosis and management of asthma. Ann. Allergy Asthma Immunol. 78: 427-437.
33. Kimura, Y., T. Miwa, L. Zhou, and W. C. Song. 2008. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Blood 111: 732-740.
34. Wang, Y., K. Mao, S. Sun, G. Lin, X. Wu, G. Yao, and B. Sun. 2009. Trichosanthin functions as Th2-type adjuvant in induction of allergic airway inflammation. Cell Res. 19: 962-972.
35. Haczku, A., K. Takeda, E. Hamelmann, J. Loader, A. Joetham, I. Redai, C. G. Irvin, J. J. Lee, H. Kikutani, D. Conrad, and E. W. Gelfand. 2000. CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 161: 952-960.
36. Jiang, Z., M. L. Fehrenbach, G. Ravaioli, B. Kokalari, I. G. Redai, S. A. Sheardown, S. Wilson, C. Macphee, and A. Haczku. 2012. The effect of lipoprotein-Associated phospholipase A2 deficiency on pulmonary allergic responses in Aspergillus fumigatus sensitized mice. Respir. Res. 13: 100.
37. Schwaeble, W., W. G. Dippold, M. K. Schäfer, H. Pohla, D. Jonas, B. Luttig, E. Weihe, H. P. Huemer, M. P. Dierich, and K. B. Reid. 1993. Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells. J. Immunol. 151: 2521-2528.
38. Schwaeble, W., H. P. Huemer, J. Möst, M. P. Dierich, M. Ströbel, C. Claus, K. B. Reid, and H. W. Ziegler-Heitbrock. 1994. Expression of properdin in human monocytes. Eur. J. Biochem. 219: 759-764.
39. Farries, T. C., and J. P. Atkinson. 1989. Biosynthesis of properdin. J. Immunol. 142: 842-847.
40. Wirthmueller, U., B. Dewald, M. Thelen, M. K. Schäfer, C. Stover, K. Whaley, J. North, P. Eggleton, K. B. Reid, and W. J. Schwaeble. 1997. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. J. Immunol. 158: 4444-4451.
41. Alcorn, J. F., C. R. Crowe, and J. K. Kolls. 2010. TH17 cells in asthma and COPD. Annu. Rev. Physiol. 72: 495-516.
42. Doe, C., M. Bafadhel, S. Siddiqui, D. Desai, V. Mistry, P. Rugman, M. McCormick, J. Woods, R. May, M. A. Sleeman, et al. 2010. Expression of the T helper 17-Associated cytokines IL-17A and IL-17F in asthma and COPD. Chest 138: 1140-1147.
43. Wilson, R. H., G. S. Whitehead, H. Nakano, M. E. Free, J. K. Kolls, and D. N. Cook. 2009. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 180: 720-730.
44. Zhang, X., I. P. Lewkowich, G. Köhl, J. R. Clark, M. Wills-Karp, and J. Kö hl. 2009. A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells. J. Immunol. 182: 5123-5130.
45. Kö hl, J., and M. Wills-Karp. 2007. A dual role for complement in allergic asthma. Curr. Opin. Pharmacol. 7: 283-289.
46. Mizutani, N., T. Nabe, and S. Yoshino. 2009. Complement C3a regulates late asthmatic response and airway hyperresponsiveness in mice. J. Immunol. 183: 4039-4046.
47. Lajoie, S., I. P. Lewkowich, Y. Suzuki, J. R. Clark, A. A. Sproles, K. Dienger, A. L. Budelsky, and M. Wills-Karp. 2010. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat. Immunol. 11: 928-935.
48. Walport, M. J. 2001. Complement. First of two parts. N. Engl. J. Med. 344: 1058-1066.
49. Walport, M. J. 2001. Complement. Second of two parts. N. Engl. J. Med. 344: 1140-1144.
50. Mollnes, T. E., W. C. Song, and J. D. Lambris. 2002. Complement in inflammatory tissue damage and disease. Trends Immunol. 23: 61-64.
51. Kirschfink, M. 1997. Controlling the complement system in inflammation. Immunopharmacology 38: 51-62.
52. Ricklin, D., and J. D. Lambris. 2013. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J. Immunol. 190: 3831-3838.
53. Holers, V. M. 2014. Complement and its receptors: new insights into human disease. Annu. Rev. Immunol. 32: 433-459.
54. Bera, M. M., B. Lu, T. R. Martin, S. Cui, L. M. Rhein, C. Gerard, and N. P. Gerard. 2011. Th17 cytokines are critical for respiratory syncytial virusassociated airway hyperreponsiveness through regulation by complement C3a and tachykinins. J. Immunol. 187: 4245-4255.
55. Mizutani, N., H. Goshima, T. Nabe, and S. Yoshino. 2012. Complement C3ainduced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice. J. Immunol. 188: 5694-5705.
56. Ali, H., and R. A. Panettieri, Jr. 2005. Anaphylatoxin C3a receptors in asthma. Respir. Res. 6: 19.
57. Drouin, S. M., M. Sinha, G. Sfyroera, J. D. Lambris, and R. A. Wetsel. 2006. A protective role for the fifth complement component (c5) in allergic airway disease. Am. J. Respir. Crit. Care Med. 173: 852-857.
58. Karp, C. L., A. Grupe, E. Schadt, S. L. Ewart, M. Keane-Moore, P. J. Cuomo, J. Köhl, L. Wahl, D. Kuperman, S. Germer, et al. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1: 221-226.
59. Taube, C., J. M. Thurman, K. Takeda, A. Joetham, N. Miyahara, M. C. Carroll, A. Dakhama, P. C. Giclas, V. M. Holers, and E. W. Gelfand. 2006. Factor B of the alternative complement pathway regulates development of airway hyperresponsiveness and inflammation. Proc. Natl. Acad. Sci. USA 103: 8084-8089.
60. Peng, T., L. Hao, J. A. Madri, X. Su, J. A. Elias, G. L. Stahl, S. Squinto, and Y. Wang. 2005. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J. Clin. Invest. 115: 1590-1600.
61. Drouin, S. M., D. B. Corry, J. Kildsgaard, and R. A. Wetsel. 2001. Cutting edge: the absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J. Immunol. 167: 4141-4145.
62. Takeda, K., J. M. Thurman, S. Tomlinson, M. Okamoto, Y. Shiraishi, V. P. Ferreira, C. Cortes, M. K. Pangburn, V. M. Holers, and E. W. Gelfand. 2012. The critical role of complement alternative pathway regulator factor H in allergen-induced airway hyperresponsiveness and inflammation. J. Immunol. 188: 661-667.
63. Kemper, C., L. M. Mitchell, L. Zhang, and D. E. Hourcade. 2008. The complement protein properdin binds apoptotic T cells and promotes complement activation and phagocytosis. Proc. Natl. Acad. Sci. USA 105: 9023-9028.
64. Gaarkeuken, H., M. A. Siezenga, K. Zuidwijk, C. van Kooten, T. J. Rabelink, M. R. Daha, and S. P. Berger. 2008. Complement activation by tubular cells is mediated by properdin binding. Am. J. Physiol. Renal Physiol. 295: F1397-F1403.
65. Kemper, C., J. P. Atkinson, and D. E. Hourcade. 2010. Properdin: emerging roles of a pattern-recognition molecule. Annu. Rev. Immunol. 28: 131-155.
66. Cortes, C., V. P. Ferreira, and M. K. Pangburn. 2011. Native properdin binds to Chlamydia pneumoniae and promotes complement activation. Infect. Immun. 79: 724-731.
67. Xu, W., S. P. Berger, L. A. Trouw, H. C. de Boer, N. Schlagwein, C. Mutsaers, M. R. Daha, and C. van Kooten. 2008. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. J. Immunol. 180: 7613-7621.